Trending:
Searched Tag: obesity related diseases
June 7, 2026, 01:51 PM - 6 min read
Beyond diabetes and obesity, GLP-1 drugs have now earned regulatory approval in several new areas. A trial of more than 17,000 people found semaglutide cut the risk of serious heart attacks and strokes by 20 per cent, even in people without diabetes.
Read moreMay 15, 2026, 06:07 PM - 3 min read
"Obesity can change how signals travel to the brain. The good news is that this may be something we can treat. Instead of looking at Alzheimer's risk tied to obesity as just a metabolic problem, this research suggests we may be able to target the process that connects those changes to the brain," co-lead researcher Stephen Wong, distinguished chair in biomedical engineering, said.
Read more
2026 News Arena India Pvt Ltd | All rights reserved | The Ideaz Factory